Xueli Wang
Binzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
FOSL2 Regulates PD-L1 and Modulates Hormone Therapy Response Heterogeneity.
Journal: Molecular cancer research : MCR
Published: June 09, 2025
A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity.
Journal: Neoplasia (New York, N.Y.)
Published: October 20, 2022
Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of LASP1 regulation.
Journal: Molecular and cellular probes
Published: June 20, 2022
RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway.
Journal: Oncogene
Published: November 15, 2021
Prognostic significance of the presence of intraductal carcinoma of the prostate and bone metastasis in needle biopsy for prostate carcinoma patients with Grade Group 5.
Journal: Pathology, research and practice
Published: July 05, 2019
Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers.
Journal: The Prostate
Published: December 14, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026